BUZZ-U.S. Stocks on the Move-Baker Hughes, Celldex, Amicus Therapeutics

Mon Nov 17, 2014 9:14am EST
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks were set to fall at the open on Monday, following four consecutive weeks of gains for major Wall Street indexes, weighed by data showing Japan slipped into recession. Dow Jones industrial average futures were down 0.19 percent at 17,571, S&P 500 futures were down 0.22 percent at 2,033.5 and Nasdaq 100 futures were down 0.16 percent at 4,215.25.

** HALLIBURTON CO, Friday close $55.08, -6.32 pct premarket

** BAKER HUGHES INC, Friday close $59.89, +13.22 pct premarket

** SCHLUMBERGER NV, Friday close $95.32, -0.36 pct premarket

Halliburton, the world's second-largest oilfield services provider, will buy smaller rival Baker Hughes for about $35 billion in cash and stock, creating an oilfield services behemoth to take on market leader Schlumberger as falling oil prices threaten to erode demand.

** CELLDEX THERAPEUTICS INC, Friday close $14.16, +18.15 pct premarket

Interim data showed the drugmaker's brain tumor drug shrunk tumor, improved survival in patients without the disease worsening.   Continued...